Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
12 studies found for:    squalamine lactate
Show Display Options
Rank Status Study
1 Withdrawn Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)
Condition: Diabetic Retinopathy
Intervention: Drug: Squalamine Lactate Ophthalmic Solution 0.2%
2 Terminated A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: MSI-1256F (Squalamine Lactate)
3 Withdrawn Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: Squalamine Lactate Ophthalmic Solution, 0.2%;   Drug: Placebo Ophthalmic Solution;   Drug: ranibizumab
4 Completed Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
Conditions: Retinal Vein Occlusion;   Macular Edema
Interventions: Drug: ranibizumab;   Drug: Squalamine Lactate Ophthalmic Solution, 0.2%
5 Terminated A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration
Condition: "Wet" Age-Related Macular Degeneration
Intervention: Drug: Squalamine Lactate
6 Terminated MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: MSI-1256F (Squalamine Lactate)
7 Unknown  Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: carboplatin;   Drug: squalamine lactate
8 Completed Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Condition: Neovascular Age Related Macular Degeneration
Interventions: Drug: Squalamine lactate;   Drug: Vehicle control
9 Terminated A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: MSI-1256F (Squalamine Lactate)
10 Active, not recruiting Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD
Condition: Age-related Macular Degeneration
Interventions: Drug: Squalamine lactate ophthalmic solution, 0.2%;   Drug: Placebo Ophthalmic solution;   Drug: ranibizumab
11 Withdrawn Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: leuprolide acetate;   Drug: squalamine lactate;   Procedure: adjuvant therapy;   Procedure: antiandrogen therapy;   Procedure: antiangiogenesis therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Procedure: releasing hormone agonist therapy
12 Completed Squalamine for the Treatment in Proliferative Diabetic Retinopathy
Condition: Retinal Neovascularization
Intervention: Drug: Squalamine Lactate ophthalmic solution 0.2%

Study has passed its completion date and status has not been verified in more than two years.